The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center

Author:

Zouridis Andreas1ORCID,Zarrindej Kianoush2,Rencher Joshua3,Pappa Christina1,Kashif Ammara1,Smyth Sarah1ORCID,Sadeghi Negin1,Sattar Alisha1ORCID,Damato Stephen1,Ferrari Federico4,Laganà Antonio5ORCID,Abdalla Mostafa6ORCID,Kehoe Sean1,Addley Susan7ORCID,Soleymani majd Hooman1ORCID

Affiliation:

1. Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK

2. Buckinghamshire NHS Foundation Trust, Bucks HP11 2TT, UK

3. Royal Berkshire NHS Foundation Trust, Reading RG1 5AN, UK

4. Department of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy

5. Unit of Gynecologic Oncology, ARNAS “Civico-Di Cristina-Benfratelli”, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy

6. Gynaecology—Guy’s and St Thomas’ NHS Foundation Trust, London SE1 9RT, UK

7. University Hospitals of Derby and Burton NHS Foundation Trust, Derby DE22 3NE, UK

Abstract

High grade endometrioid endometrial cancer (HGEEC) is a heterogeneous group of tumors with unclear prognostic features. The aim of the present study is to evaluate the independent risk factors for recurrence and mortality and to describe the recurrence patterns of HGEEC. Ninety-six consecutive cases of HGEEC treated with primary surgery in a single Tertiary Center were retrospectively reviewed. Clinicopathological and treatment details were recorded, and all patients were closely followed up. Disease-free, overall and cancer-specific survival rates were 83.8%, 77.8% and 83.6%, respectively. Cervical stromal involvement was independently related to recurrence (HR = 25.67; 95%CI 2.95–223.30; p = 0.003) and cancer-related death (HR = 15.39; 95%CI 1.29–183.43; p = 0.031) after adjusting for other pathological and treatment variables. Recurrence rate was 16%, with 60% of these cases having lung metastases and only one case with single vaginal vault recurrence. 81.81% of the recurrences presented with symptoms and not a single recurrence was diagnosed in routine follow-up clinical examination. In conclusion, the recurrence pattern may suggest that patient-initiated follow-up (PIFU) could be considered a potential alternative to clinical-based follow-up for HGEEC survivors, especially for patients without cervical involvement and after two years from treatment. Additional caution is needed in patients with cervical stromal involvement.

Publisher

MDPI AG

Subject

General Medicine

Reference40 articles.

1. Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019, A Systematic Analysis for the Global Burden of Disease Study 2019;Kocarnik;JAMA Oncol.,2022

2. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer;Colombo;Ann. Oncol.,2016

3. Cancer of the corpus uteri: 2021 update;Koskas;Int. J. Gynaecol. Obstet. Off. Organ. Int. Fed. Gynaecol. Obstet.,2021

4. Two pathogenetic types of endometrial carcinoma;Bokhman;Gynecol. Oncol.,1983

5. Latest developments and techniques in gynaecological oncology surgery;Ferrari;Curr. Opin. Obstet. Gynecol.,2015

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3